Your browser doesn't support javascript.
loading
Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis.
Chen, Yihong; Gialeli, Chrysostomi; Shen, Junyan; Dunér, Pontus; Walse, Björn; Duelli, Annette; Caing-Carlsson, Rhawnie; Blom, Anna M; Zibert, John R; Nilsson, Anna Hultgårdh; Alenfall, Jan; Liang, Chun; Nilsson, Jan.
Afiliação
  • Chen Y; Department of Cardiology, Second Affiliated Hospital of Naval Medical University, Shanghai Cardiovascular Institute of Integrative Medicine, Shanghai, China; Department of Experimental Medical Science, Lund University, Sweden.
  • Gialeli C; Department of Clinical Sciences Malmö, Lund University, Sweden.
  • Shen J; Department of Experimental Medical Science, Lund University, Sweden; Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Dunér P; Department of Clinical Sciences Malmö, Lund University, Sweden.
  • Walse B; SARomics Biostructures AB, Lund, Sweden.
  • Duelli A; SARomics Biostructures AB, Lund, Sweden.
  • Caing-Carlsson R; SARomics Biostructures AB, Lund, Sweden.
  • Blom AM; Department of Translational Medicine, Lund University, Sweden.
  • Zibert JR; Coegin Pharma AB, Lund, Sweden.
  • Nilsson AH; Department of Experimental Medical Science, Lund University, Sweden.
  • Alenfall J; Department of Clinical Sciences Malmö, Lund University, Sweden; Coegin Pharma AB, Lund, Sweden.
  • Liang C; Department of Cardiology, Second Affiliated Hospital of Naval Medical University, Shanghai Cardiovascular Institute of Integrative Medicine, Shanghai, China. Electronic address: chunliangliang@126.com.
  • Nilsson J; Department of Clinical Sciences Malmö, Lund University, Sweden. Electronic address: jan.nilsson@med.lu.se.
Pharmacol Res ; 205: 107259, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38871237
ABSTRACT
The osteopontin-derived peptide FOL-005 stimulates hair growth. Using ligand-receptor glyco-capture technology we identified neuropilin-1 (NRP-1), a known co-receptor for vascular endothelial growth factor (VEGF) receptors, as the most probable receptor for FOL-005 and the more stable analogue FOL-026. X-ray diffraction and microscale thermophoresis analysis revealed that FOL-026 shares binding site with VEGF in the NRP-1 b1-subdomain. Stimulation of human umbilical vein endothelial cells with FOL-026 resulted in phosphorylation of VEGFR-2, ERK1/2 and AKT, increased cell growth and migration, stimulation of endothelial tube formation and inhibition of apoptosis in vitro. FOL-026 also promoted angiogenesis in vivo as assessed by subcutaneous Matrigel plug and hind limb ischemia models. NRP-1 knock-down or treatment of NRP-1 antagonist EG00229 blocked the stimulatory effects of FOL-026 on endothelial cells. Exposure of human coronary artery smooth muscle cells to FOL-026 stimulated cell growth, migration, inhibited apoptosis, and induced VEGF gene expression and VEGFR-2/AKT phosphorylation by an NRP-1-dependent mechanism. RNA sequencing showed that FOL-026 activated pathways involved in tissue repair. These findings identify NRP-1 as the receptor for FOL-026 and show that its biological effects mimic that of growth factors binding to the VEGF receptor family. They also suggest that FOL-026 may have therapeutical potential in conditions that require vascular repair and/or enhanced angiogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização Fisiológica / Neuropilina-1 / Osteopontina / Células Endoteliais da Veia Umbilical Humana Limite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neovascularização Fisiológica / Neuropilina-1 / Osteopontina / Células Endoteliais da Veia Umbilical Humana Limite: Animals / Humans / Male Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article